Media releases

Novartis Newsroom

Media releases

Select a language: en | de | fr

Select a year: 2008 | 2007 | 2006

December 22, 2006

Exforge® receives US regulatory approval as a new and highly effective treatment option for patients with high blood pressure

December 14, 2006

Novartis making significant progress in creating new strategic growth platform in human vaccines, names site for new division headquarters

December 14, 2006

Novartis to further focus on healthcare, reaching agreement to sell its Medical Nutrition business

December 14, 2006

Novartis announces three-month extension of US regulatory review period for Tekturna®

December 11, 2006

Pivotal submission data shows Tasigna® achieved impressive response rates in chronic myeloid leukemia patients no longer helped by Glivec®

December 06, 2006

Glivec® demonstrates highest five-year overall survival rate in history of treatment for patients with chronic myeloid leukemia

December 06, 2006

New evidence reinforces efficacy and tolerability of Galvus® as a new once-daily oral treatment option for patients with type 2 diabetes

November 28, 2006

Novartis highlights strong R&D pipeline, plans for multiple new product launches and novel projects moving into late-stage trials

November 20, 2006

Novartis secures contract to supply additional H5N1 influenza vaccine to the US government

November 17, 2006

Novartis to provide additional clarification to EU regulators on data supporting approval of Mycograb® for serious fungal infections

‹ 1-10 11-20 ›

45 Total results

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

SWX

NYSE

NOVZn

See stock performance

NVS

See stock performance

Event calendar

Find out about past and upcoming events (e.g. sales results, pipeline updates and shareholder meetings) and download presentations.

Media releases

Event calendar

Get Novartis Media Releases through RSS

Stay Connected